ReviewWorld journal of diabetes2021

Current advances in using tolerogenic dendritic cells as a therapeutic alternative in the treatment of type 1 diabetes.

William de Jesús Ríos-Ríos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.